• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化进展发生在具有典型组织学特征的重度饮酒者亚组中。

Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.

作者信息

Mathurin P, Beuzin F, Louvet A, Carrié-Ganne N, Balian A, Trinchet J C, Dalsoglio D, Prevot S, Naveau S

机构信息

Service Maladies de l'Appareil Digestif, Hôpital Huriez, CHRU de Lille, Lille, and ISERM 0114, Univ de Lille, Lille, France.

出版信息

Aliment Pharmacol Ther. 2007 May 1;25(9):1047-54. doi: 10.1111/j.1365-2036.2007.03302.x.

DOI:10.1111/j.1365-2036.2007.03302.x
PMID:17439505
Abstract

BACKGROUND

Studies using consecutive liver biopsies constitute an attractive approach to gaining insight into the pathogenesis of alcoholic liver disease.

AIM

To analyse histological factors at baseline, which are predictive of fibrosis progression and recurrence of alcoholic hepatitis.

RESULTS

A total of 193 drinkers underwent consecutive biopsies at an interval of 4 years. At baseline, 20 had normal livers, 135 steatosis, five fibrosis and 33 alcoholic hepatitis. The fibrosis score increased from 1.07 +/- 0.07 to 1.7 +/- 0.94 (P < 0.001). In multivariate analysis, only steatosis (P = 0.04), alcoholic hepatitis (P = 0.0004) and stage of fibrosis (P < 0.0001) were independent predictive factors of the fibrosis score at the second biopsy. Cirrhosis developed more frequently in patients with steatosis (11%) and alcoholic hepatitis (39%) than in others (0%, P < 0.0001). Alcoholic hepatitis recurred more frequently in patients with alcoholic hepatitis at baseline: 58% vs. 15%, P < 0.0001. In multivariate analysis, alcoholic hepatitis at the first biopsy was the only predictive factor of its recurrence (P < 0.0001).

CONCLUSIONS

In a large cohort of drinkers with consecutive biopsies, steatosis, fibrosis stage and alcoholic hepatitis at baseline were independent predictive factors of fibrosis progression. In terms of mechanisms, we propose a novel concept of multiple hits of alcoholic hepatitis occurring in the same patient.

摘要

背景

采用连续肝活检的研究是深入了解酒精性肝病发病机制的一种有吸引力的方法。

目的

分析基线时的组织学因素,这些因素可预测纤维化进展和酒精性肝炎复发。

结果

共有193名饮酒者每隔4年接受连续活检。基线时,20人肝脏正常,135人有脂肪变性,5人有纤维化,33人有酒精性肝炎。纤维化评分从1.07±0.07增加到1.7±0.94(P<0.001)。多因素分析显示,只有脂肪变性(P=0.04)、酒精性肝炎(P=0.0004)和纤维化分期(P<0.0001)是第二次活检时纤维化评分的独立预测因素。脂肪变性患者(11%)和酒精性肝炎患者(39%)发生肝硬化的频率高于其他患者(0%,P<0.0001)。基线时有酒精性肝炎的患者酒精性肝炎复发更频繁:58%对15%,P<0.0001。多因素分析显示,首次活检时的酒精性肝炎是其复发的唯一预测因素(P<0.0001)。

结论

在一大群接受连续活检的饮酒者中,基线时的脂肪变性、纤维化分期和酒精性肝炎是纤维化进展的独立预测因素。在机制方面,我们提出了同一患者发生多次酒精性肝炎打击的新概念。

相似文献

1
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.纤维化进展发生在具有典型组织学特征的重度饮酒者亚组中。
Aliment Pharmacol Ther. 2007 May 1;25(9):1047-54. doi: 10.1111/j.1365-2036.2007.03302.x.
2
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.脂肪变性对轻度丙型肝炎患者纤维化进展的影响。
Hepatology. 2005 Jan;41(1):82-7. doi: 10.1002/hep.20519.
3
The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.肝脂肪变性对慢性丙型肝炎感染自然史的影响。
J Viral Hepat. 2009 Jul;16(7):492-9. doi: 10.1111/j.1365-2893.2009.01098.x. Epub 2009 Feb 5.
4
[Predictive risk factors for progression to cirrhosis in early stage alcoholic liver disease].[早期酒精性肝病进展为肝硬化的预测风险因素]
Gastroenterol Clin Biol. 1998 Dec;22(12):997-1002.
5
Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.慢性丙型肝炎中的脂肪变性:肥胖、糖尿病和酒精的相对作用。
Hepatology. 2002 Sep;36(3):729-36. doi: 10.1053/jhep.2002.35064.
6
Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.供体移植物脂肪变性对丙型肝炎病毒肝硬化肝移植术后总体结局及病毒复发的影响。
Liver Transpl. 2009 Jan;15(1):37-48. doi: 10.1002/lt.21566.
7
Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.预测慢性丙型肝炎病毒感染患者后续肝活检时的进行性肝纤维化阶段。
J Viral Hepat. 2005 Jan;12(1):74-80. doi: 10.1111/j.1365-2893.2005.00598.x.
8
Predictive factors for pure steatosis in alcoholic patients.酒精性肝病患者单纯性脂肪变性的预测因素
Alcohol Clin Exp Res. 2009 Jun;33(6):1104-10. doi: 10.1111/j.1530-0277.2009.00932.x. Epub 2009 Mar 23.
9
Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?病态肥胖的非酒精性脂肪性肝炎患者发生严重肝纤维化的预测因素有哪些?
Obes Surg. 2001 Jun;11(3):254-7. doi: 10.1381/096089201321336548.
10
Portal lymphocytic infiltrate in alcoholic liver disease.酒精性肝病中的门管区淋巴细胞浸润。
Hum Pathol. 2002 Dec;33(12):1170-4. doi: 10.1053/hupa.2002.129414.

引用本文的文献

1
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.代谢功能障碍与酒精性肝病(MetALD):酒精性肝病专家小组立场声明
J Hepatol. 2025 Apr;82(4):744-756. doi: 10.1016/j.jhep.2024.11.028. Epub 2024 Nov 27.
2
Alcohol-associated liver disease: Natural history, management and novel targeted therapies.酒精性肝病:自然史、管理与新型靶向治疗
Clin Mol Hepatol. 2025 Feb;31(Suppl):S112-S133. doi: 10.3350/cmh.2024.0709. Epub 2024 Oct 31.
3
Gut Bacteria in Alcohol-Associated Liver Disease.
肠道细菌与酒精性肝病。
Clin Liver Dis. 2024 Nov;28(4):663-679. doi: 10.1016/j.cld.2024.06.008. Epub 2024 Jul 24.
4
Fecal gelatinase does not predict mortality in patients with alcohol-associated hepatitis.粪便明胶酶不能预测酒精性肝炎患者的死亡率。
Microb Cell. 2024 Aug 26;11:328-338. doi: 10.15698/mic2024.08.836. eCollection 2024.
5
Non-Invasive Biomarkers for Differentiating Alcohol Associated Hepatitis from Acute Decompensation in Patients with ALD.用于区分酒精性肝病患者酒精性肝炎与急性失代偿的非侵入性生物标志物
J Clin Med. 2024 Jun 27;13(13):3747. doi: 10.3390/jcm13133747.
6
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma.I 型干扰素在肝细胞癌中的作用机制与治疗。
Clin Transl Oncol. 2024 Feb;26(2):326-337. doi: 10.1007/s12094-023-03266-7. Epub 2023 Jul 4.
7
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.全球酒精相关性肝病的患病率、发病率和结局:系统评价和荟萃分析。
BMC Public Health. 2023 May 11;23(1):859. doi: 10.1186/s12889-023-15749-x.
8
The Ethanolic Extract of Lindera aggregata Modulates Gut Microbiota Dysbiosis and Alleviates Ethanol-Induced Acute Liver Inflammation and Oxidative Stress SIRT1/Nrf2/NF-B Pathway.乌药醇提物通过调节肠道菌群失调缓解乙醇诱导的急性肝炎症和氧化应激 SIRT1/Nrf2/NF-B 通路。
Oxid Med Cell Longev. 2022 Dec 20;2022:6256450. doi: 10.1155/2022/6256450. eCollection 2022.
9
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors.全球酒精性肝硬化和 HCC 的流行病学:趋势、预测和危险因素。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18.
10
Advancements in the Alcohol-Associated Liver Disease Model.酒精相关性肝病模型的进展。
Biomolecules. 2022 Jul 27;12(8):1035. doi: 10.3390/biom12081035.